RWD92 Prevalence and Factors Associated with the Use of Direct Oral Anticoagulants Andlow Molecular Weight Heparins (LMWH) in Cancer Patients

M.L Johnson,S Yande,R.R Aparasu,M Wanat,K Toale

doi:10.1016/j.jval.2023.03.2121

RWD92 Prevalence and Factors Associated with the Use of Direct Oral Anticoagulants Andlow Molecular Weight Heparins (LMWH) in Cancer Patients

M.L Johnson, S Yande + Show 3 more

https://doi.org/10.1016/j.jval.2023.03.2121

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Publication Date: Jun 1, 2023

Affiliation: RTI Health Solutions, University of Houston, The University of Texas MD Anderson Cancer Center

#Use Of Direct Oral Anticoagulants #Low-molecular Weight Heparins + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Venous thromboembolism (VTE) is a fatal comorbidity prevalent in cancer patients. Low-molecular weight heparins (LMWHs) have been the preferred treatment for cancer associated thrombosis (CAT). Direct-oral anticoagulants (DOACs) are a relatively newer drug class used for treating CAT. Treatment guidelines provide inconsistent recommendations. This study aimed to study the prevalence and predictors associated with utilization of these anticoagulation strategies.

Full Text